Association between oral fluoroquinolone use and the development of retinal detachment: A systematic review and meta-analysis of observational studies

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 4, 2014, Pages 971-978

  Chui, Celine S L ^a   Wong, Ian C K ^a   Wong, Lisa Y L ^a   Chan, Esther W ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adverse drug reactions; Pharmacoepidemiology; Retina

Indexed keywords

QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ARTICLE; CASE STUDY; DISEASE ASSOCIATION; HUMAN; INCIDENCE; META ANALYSIS; OBSERVATIONAL STUDY; PRESCRIPTION; RETINA DETACHMENT; RISK ASSESSMENT; SYSTEMATIC REVIEW; CHEMICALLY INDUCED; ORAL DRUG ADMINISTRATION; RETINAL DETACHMENT;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; FLUOROQUINOLONES; HUMANS; RETINAL DETACHMENT;

EID: 84926459356     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku507     Document Type: Article

References (21)

1. Etminan M, Forooghian F, Brophy JM et al. Oral fluoroquinolones and the risk of retinal detachment. JAMA 2012; 307: 1414-9.
2. US FDA. Potential Signals of Serious Risks/NewSafety Information Identified by the Adverse Event Reporting System (AERS) Between April-June 2012. http://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/surveillance/adversedrugeffects/ucm324020.htm.
3. EMA. Pharmacovigilance Risk Assessment Committee (PRAC) Minutes of the Meeting, 29-31 October 2012. http://www.ema.europa.eu/docs/en_GB/document_library/Minutes/2012/12/WC500135712.pdf.
4. Health Canada. Canadian Adverse Reaction Newsletter, Volume 23, Issue 3, July 2013. http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/carn-bcei_v23n3-eng.php#article1.
5. Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.
6. Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:2008-12.
7. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. www.cochrane-handbook.org.
8. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
9. Chui CS, Man KK, Cheng CL et al. An investigation of the potential association between retinal detachment and oral fluoroquinolones: a selfcontrolled case series study. J Antimicrob Chemother 2014; 69: 2363-7.
10. Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 1927; 22: 209-12.
11. Population Data BC. https://www.popdata.bc.ca/home.
12. Fife D, Zhu V, Voss E et al. Exposure to oral fluoroquinolones and the risk of retinal detachment: retrospective analyses of two large healthcare databases. Drug Saf 2014; 37: 171-82.
13. Pasternak B, Svanstrom H, Melbye M et al. Association between oral fluoroquinolone use and retinal detachment. JAMA 2013; 310: 2184-90.
14. Kuo SC, Chen YT, Lee YT et al. Association between recent use of fluoroquinolones and rhegmatogenous retinal detachment: a populationbased cohort study. Clin Infect Dis 2014; 58: 197-203.
15. Kapoor KG, Hodge DO, St Sauver JL et al. Oral fluoroquinolones and the incidence of rhegmatogenous retinal detachment and symptomatic retinal breaks: a population-based study. Ophthalmology 2014; 121: 1269-73.
16. Eftekhari K, Ghodasra DH, Haynes K et al. Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study. Pharmacoepidemiol Drug Saf 2014; 23: 745-52.
17. Farioli A, Kriebel D. Incidence rates of retinal detachment in 2 cohorts of patients treated with oral fluoroquinolones or amoxicillin. Clin Infect Dis 2014; 58: 1489-90.
18. Mitry D, Charteris DG, Fleck BW et al. The epidemiology of rhegmatogenous retinal detachment: geographical variation and clinical associations. Br J Ophthalmol 2010; 94: 678-84.
19. Hsieh CY, Chen CH, Li CYet al. Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database. J Formos Med Assoc 2013; doi: 10.1016/j.jfma.2013.09.009.
20. Denburg MR, Haynes K, Shults J et al. Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease. Pharmacoepidemiol Drug Saf 2011; 20: 1138-49.
21. Holland-Bill L, Christiansen CF, Ulrichsen SP et al. Validity of the International Classification of Diseases, 10th revision discharge diagnosis codes for hyponatraemia in the Danish National Registry of Patients. BMJ Open 2014; 4: e004956.